Please provide your email address to receive an email when new articles are posted on . Patients had lower potassium levels and normokalemia within 15 days of potassium treatment. Patients on ...

The potassium binder Veltassa (patiromer), approved by the FDA in October 2015 for the treatment of hyperkalemia, is now available via prescription. Patients prescribed Veltassa will receive the ...

blood test Nearly 74% of hemodialysis patients experienced pre-dialysis hyperkalemia within 1 year of enrollment in the Dialysis Outcomes and Practice Patterns Study, according to investigators. In ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nihar R. Desai, MD ...

The approval was based on data from the Phase 4 TOURMALINE trial which randomized 114 patients with hyperkalemia to receive Valtessa once daily with food or without food for 4 weeks The prescribing ...